Phaseline

Targets › Ion channels

Ion channels: drug programs, companies and trials

134 programs from 122 companies in 489 trials: 169 Phase 4, 143 Phase 2, 106 Phase 3, 71 Phase 1; Neurology, Cardiovascular, Other; next expected readout Nov 2026.

Open in Phaseline: the race on Ion channels, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Mayo ClinicBCG Solution
Glucagon-like peptide 1 receptor agonist
GLP1R, Ion channels, CD38, OPRM1, PDCD1, CD274Phase 4Pain, Postoperative; Limb Pain, Phantom; Healthy; Respiratory Function Loss …Nov 2026
Vanderbilt University Medical Center[18F]MH.MZ
Bacterial penicillin-binding protein inhibitor
HTR2A, UNKNOWN, BDKRB2, Ion channelsPhase 4Neurodegenerative Diseases; Osteoarthritis, Knee; Pain; Intradialytic Hypotension …Nov 2026
Jiangsu HengRui MedicineBupivacaine
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 4Local Analgesia Via Infiltration; Local Analgesia Via Nerve Block; Robotic Lung Surgery; Low Back Pain …Nov 2026
University of Pennsylvania2-[18F]-FA
Voltage-gated calcium channel modulator
CHRNA4, OPRK1, OPRD1, OPRM1, UL51, ADRA2A, ADRA2C, ADRA2B, Ion channels, CACNB4, CACNB2, CACNB1, CACNB3, TNF, SLC6A4, HTR2A, HTR2C, FKBP1A, CD86, CD80, PDE4A, PDE4D, PDE4B, PDE4C, PDE3A, CHRNB2, STNPhase 4Alcohol Use Disorder; Acute Kidney Injury; Insomnia; Giant Cell Arteritis …Nov 2026
Fayoum University HospitalLidocaine Hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 4CADNov 2026
Retina Research Institute, LLCChloroprocaine
Sodium channel alpha subunit blocker
Ion channelsPhase 4No ConditionDec 2026
Vertex PharmaceuticalsSuzetrigine (SUZ, VX-548)
Nav1.9 sodium channel inhibitor
Ion channelsPhase 4Pain; Diabetic Peripheral Neuropathic Pain; Opioid Consumption, Postoperative; Bariatric Surgery …Jan 2027
ViatrisGabapentin
Voltage-gated calcium channel modulator
Ion channels, CACNB4, CACNB2, CACNB1, CACNB3Phase 4Healthy; Tonsillitis; Dental Pain and Sensation Disorder; Pain, Postoperative …Jan 2027
Duke UniversityMepivacaine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Tourniquet HypertensionFeb 2027
All India Institute of Medical Sciences, JodhpurLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 4SeizuresMar 2027
Bangladesh Medical UniversityMirogabalin
Voltage-gated calcium channel alpha2/delta subunit 1 modulator; Voltage-gated calcium channel alpha2/delta subunit 2 modulator
Ion channelsPhase 4Diabetic Peripheral Neuropathic Pain (DPNP)Mar 2027
All India Institute of Medical Sciences, JodhpurPhenytoin
Sodium channel alpha subunit blocker
Ion channelsPhase 4SeizuresMar 2027
Morten Steen Kvistholm JensenVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Non-obstructive Hypertrophic CardiomyopathyApr 2027
Wake Forest University Health Scienceslacosamide
Sodium channel alpha subunit blocker
Ion channelsPhase 4Traumatic Brain InjuryApr 2027
Brigham and Women's HospitalBupivacaine Hydrochloride
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 4Labor PainJun 2027
Anne E. Zepeskidiltiazem
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Supraventricular Tachycardia (SVT)Jul 2027
University of California, Los AngelesNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Postpartum Hypertension (PPHT)Jul 2027
Affiliated Hospital of Nantong UniversityZonisamide
Sodium channel alpha subunit blocker
Ion channelsPhase 4Epilepsies, PartialJul 2027
Duke UniversityChloroprocaine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Knee Stiffness After Total Knee ArthroplastyAug 2027
Guangdong Provincial People's HospitalCrisugabalin
Calcium channel alpha-2-delta subunit ligand
Ion channelsPhase 4PARKINSON DISEASE (Disorder)Aug 2027
Kumamoto UniversityNicorandil
ATP-sensitive potassium channel opener
Ion channelsPhase 4Coronary Artery DiseaseAug 2027
Centre Hospitalier Universitaire de NiceVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Cluster HeadacheSep 2027
University Hospital Dubravalevobupivacaine
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 4Inguinal Hernia; Breast TumorsSep 2027
Chinese University of Hong KongLevobupivacaine
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 4Musculoskeletal Diseases or ConditionsSep 2027
Aarhus University HospitalNicardipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Intracerebral HaemorrhageSep 2027
University Hospital Bispebjerg and FrederiksbergLamotrigine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Bipolar II DisorderDec 2027
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauAmiodarone Hydrochloride
HERG blocker
Ion channelsPhase 4Persistent Atrial FibrillationDec 2027
Leiden University Medical CenterLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 4GliomaJan 2028
Algemeen Ziekenhuis Maria MiddelaresLevobupivacaine
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 4Analgesic EffectFeb 2028
Nebraska Methodist Health SystemNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Postpartum Preeclampsia; Hypertension in PregnancyJul 2028
Shenzhen Ausa PharmedAmlodipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Hypertension; Atrial Fibrillation; Diabetes Mellitus, Type 2; Stroke …Jun 2029
Universitaire Ziekenhuizen KU Leuvenflecainide
Sodium channel protein type V alpha subunit blocker
Ion channelsPhase 4Atrial Fibrillation (AF)Dec 2029
Stanford UniversityAmiodarone
HERG blocker
Ion channelsPhase 4Postoperative Atrial FibrillationDec 2030
Yan LiAmlodipine besylate
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 4Hypertension–
University of Illinois ChicagoFlecainide
Sodium channel protein type V alpha subunit blocker
Ion channelsPhase 4Atrial Fibrillation–
University of Texas at AustinGabapentin Enacarbil
Voltage-gated calcium channel modulator
Ion channels, CACNB4, CACNB2, CACNB1, CACNB3Phase 4Alzheimer Disease–
Jinnah Postgraduate Medical CentreOxcarbazepine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Trigeminal Neuralgia–
University of South FloridaPhenazopyridine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Pain After Urodynamic Testing–
Louisiana State University Health Sciences Center in New OrleansProparacaine
Sodium channel alpha subunit blocker
Ion channelsPhase 4Epiphora–
University of Illinois ChicagoSotalol
Beta-1 adrenergic receptor antagonist; HERG blocker; Beta-2 adrenergic receptor antagonist
ADRB1, Ion channels, ADRB2Phase 4Atrial Fibrillation–
Assiut UniversityBupivacaine Hydrochloride
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 3Cleft PalateNov 2026
Assistance Publique - Hôpitaux de ParisNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 3Preterm Premature Rupture of MembraneNov 2026
Industrial Farmacéutica CantabriaMinoxidil
Sulfonylurea receptor 2, Kir6.2 opener
Ion channels, ABCC9Phase 3Androgenetic Alopecia; Central Centrifugal Cicatricial Alopecia (CCCA); Survivors of Childhood Cancer; Breast ReconstructionNov 2026
Xenon PharmaceuticalsAzetukalner
hERG potassium channel blocker
Ion channelsPhase 3Major Depressive Disorder; Bipolar Disorder; Bipolar DepressionDec 2026
Radboud University Medical CenterDiltiazem
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 3Microvascular AnginaDec 2026
Praxis Precision Medicineselsunersen
antisense oligonucleotide targeting SCN2A
Ion channelsPhase 3Epileptic EncephalopathyDec 2026
Tata Memorial Hospital0.5% lignocaine 60mM
Voltage-gated sodium channel blocker
Ion channelsPhase 3Operable Breast CancerDec 2026
Versailles HospitalAmiodarone
HERG blocker
Ion channelsPhase 3Ventricular Arrhythmias and Cardiac ArrestJan 2027
Jilin Heart HospitalAmiodarone
HERG blocker
Ion channelsPhase 3Atrial Fibrillation (AF)Jan 2027
University of Sao PauloLacosamide
Sodium channel alpha subunit blocker
Ion channelsPhase 3Bipolar Affective DisorderJan 2027
Beijing Tiantan HospitalLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 3Postoperative Seizures After Brain Tumor SurgeryJan 2027
LupinMexiletine
Sodium channel alpha subunit blocker
Ion channelsPhase 3Myotonia; Myotonic Dystrophy; Spinal and Bulbar Muscular AtrophyJan 2027
University of California, San FranciscoRopivacaine Hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 3Pregnancy; Adolescent Idiopathic Scoliosis (AIS)Jan 2027
Ono PharmaceuticalONO-2017
Sodium channel modulator; GABA-A receptor positive allosteric modulator
Ion channels, GABRA1Phase 3Epilepsy, GeneralizedJan 2027
Tanta UniversityNicorandil 5 MG Oral Tablet
Potassium channel activator with anti-inflammatory properties
Ion channelsPhase 3Rhumatoid ArthisisMar 2027
Stoke Therapeuticszorevunersen
antisense oligonucleotide targeting SCN1A
Ion channelsPhase 3Dravet SyndromeMar 2027
Newron PharmaceuticalsEvenamide
Sodium channel alpha subunit blocker
Ion channelsPhase 3Treatment-resistant SchizophreniaMar 2027
Memorial Sloan Kettering Cancer CenterAmiodarone
HERG blocker
Ion channelsPhase 3Thoracic SurgeryApr 2027
Xenon PharmaceuticalsXEN1101
Kv7 channel opener
Ion channelsPhase 3Primary Generalized Tonic-Clonic Seizures; Focal Onset Seizures; Focal EpilepsyApr 2027
Milestone Pharmaceuticals Inc.Etripamil NS
L-type calcium channel blocker
Ion channelsPhase 3Atrial Fibrillation; Paroxysmal Supraventricular TachycardiaJun 2027
Brainfarma Industria Química e Farmacêutica S/APregabalin
Voltage-gated calcium channel modulator
Ion channels, CACNB4, CACNB2, CACNB1, CACNB3Phase 3Diabetic Neuropathy; Shoulder Arthropathy; Pregabalin; Diabetic Pruritus …Jun 2027
LXO IrelandCocaine
Sodium channel alpha subunit blocker
Ion channelsPhase 3ENT DisorderDec 2027
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 3Down SyndromeDec 2027
Zhejiang Sunshine Mandi PharmaceuticalMinoxidil
Sulfonylurea receptor 2, Kir6.2 opener
Ion channels, ABCC9Phase 3Androgenetic AlopeciaDec 2027
Loma Linda UniversityNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 3Postpartum ComplicationDec 2027
Oregon Health and Science UniversityAmiodarone Hydrochloride
HERG blocker
Ion channelsPhase 3Cardiac ArrestDec 2027
Nantes University HospitalLidocaine hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 3Vaso-Occlusive Pain Episode in Sickle Cell DiseaseAug 2028
Oslo University HospitalFlecainide
Sodium channel protein type V alpha subunit blocker
Ion channelsPhase 3Mitral Valve ProlapseAug 2028
Waad AlkathiriLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 3EpilepsyDec 2028
Shanghai East HospitalLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 3Suspected StrokeDec 2028
Samsung Medical CenterZastaprazan citrate
Potassium competitive acid blocker (P-CAB)
Ion channelsPhase 3Acute Myocardial Infarction (AMI)Dec 2029
Tanta Universityethosuximide
T-type calcium channel blocker
Ion channelsPhase 3IBS - Irritable Bowel SyndromeDec 2030
Population Health Research InstituteAmiodarone Hydrochloride
HERG blocker
Ion channelsPhase 3Atrial Fibrillation New OnsetDec 2030
Tata Memorial CentreLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 3SeizuresJun 2031
Qassim Health ClusterArticaine
Sodium channel alpha subunit blocker
Ion channelsPhase 3Dental Caries in Children–
Soleno TherapeuticsDiazoxide
Potassium channel, inwardly rectifying, subfamily J, member 11 opener; Potassium channel, inwardly rectifying, subfamily J, member 8 opener
Ion channelsPhase 3Prader-Willi Syndrome; Diabetes Mellitus; Hyperinsulinemia–
Hippocration General HospitalFlecainide
Sodium channel protein type V alpha subunit blocker
Ion channelsPhase 3Atrial Fibrillation Paroxysmal–
Assistance Publique - Hôpitaux de ParisFlecainide
Sodium channel protein type V alpha subunit blocker
Ion channelsPhase 3Patent Foramen Ovale–
Grace TherapeuticsGTX-104
Nimodipine IV infusion - dihydropyridine calcium channel blocker
Ion channelsPhase 3Aneurysmal Subarachnoid Hemorrhage (aSAH)–
AbbVieLidocaine
Sodium channel alpha subunit blocker
Ion channelsPhase 3Mid Face Volume Deficit; Blood Gas Analysis; Hemiplegia; Rib Fractures …–
Medical College of WisconsinNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 3Preeclampsia; Hypertensive Disorder of Pregnancy–
TLC BiopharmaceuticalsRopivacaine (TLC590)
Sodium channel alpha subunit blocker
Ion channelsPhase 3Postoperative Pain; Postsurgical Pain Management; End Stage Renal Disease (ESRD); Hepatic Resection …–
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCrisugabalin
Voltage-gated calcium channel alpha-2-delta subunit ligand
Ion channelsPhase 2Neuropathic PainNov 2026
Memorial Sloan Kettering Cancer CenterGlipizide
Sulfonylurea receptor 1, Kir6.2 blocker
Ion channels, ABCC8Phase 2Pancreatic CancerDec 2026
Actio BiosciencesABS-1230
KCNT1 inhibitor
Ion channelsPhase 2KCNT1-Related EpilepsyDec 2026
Biohaven TherapeuticsBHV-7000
ATP-sensitive potassium channel opener
Ion channelsPhase 2Focal Epilepsy; Familial ErythromelalgiaDec 2026
Johns Hopkins UniversityLevetiracetam (AGB101)
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 2Parkinson Disease Psychosis; Hippocampal OveractivityDec 2026
National Medical Research Center for Cardiology, Ministry of Health of Russian FederationRefralon®
I_K,ACh channel antagonist; I_to current inhibitor; anti-arrhythmic
Ion channelsPhase 2Atrial FibrillationDec 2026
Daniel Raper, MBBSLidocaine hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 2Headaches Associated With Subarachnoid Hemorrhage (SAH)Jan 2027
Anhui Medical UniversityCrisugabalin
alpha-2-delta ligand
Ion channelsPhase 2Generalized Anxiety DisorderJan 2027
Ain Shams UniversityVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 2Type 1 Diabetes MellitusFeb 2027
University of AlbertaRanolazine
Sodium channel protein type V alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 2Pulmonary HypertensionMar 2027
Tavo BiotherapeuticsTB0001 ophthalmic solution 0.9%
GABA analog; voltage-gated calcium channel modulator
Ion channelsPhase 2Primary Open - Angle Glaucoma (POAG)Jun 2027
VM TherapeuticsVMD-3866 Gel
T-type calcium channel inhibitor
Ion channelsPhase 2Chemotherapy-induced Peripheral NeuropathyJun 2027
University of California, San DiegoLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 2Neonatal SeizureJul 2027
John ElfarDalfampridine
Voltage-gated potassium channel blocker
Ion channelsPhase 2Nerve Injury; Wounds; BurnsJul 2027
Ain Shams UniversityNicorandil
ATP-sensitive potassium channel opener with nitrate-like vasodilatory properties
Ion channelsPhase 2Rheumatoid Arthritis (RA)Jul 2027
University of California, IrvineRiluzole
Sodium channel alpha subunit blocker
Ion channelsPhase 2Breast CancerJul 2027
OHSU Knight Cancer InstituteAmiodarone Hydrochloride
HERG blocker
Ion channelsPhase 2Atrial FibrillationAug 2027
Washington State UniversityZonisamide
Sodium channel alpha subunit blocker
Ion channelsPhase 2Alcohol Use Disorder (AUD)Aug 2027
HB BioTechHB-1
Angiotensin II receptor antagonist (telmisartan) and calcium channel blocker (verapamil)
AGTR1, Ion channelsPhase 2PTSDSep 2027
Sunnybrook Health Sciences CentreLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 2Hippocampal HyperactivationDec 2027
University Hospital, Basel, SwitzerlandNicardipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 2Hepato Cellular Carcinoma (HCC)Jun 2028
Swathy Chandrashekhar, MBBSRanolazine
Sodium channel protein type V alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 2Amyotrophic Lateral SclerosisJul 2028
University of FloridaVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 2Type 1 DiabetesNov 2028
Ayal A. Aizer, MDLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 2SeizuresFeb 2029
BiossilSenicapoc (SIL-8301)
Intermediate conductance calcium-activated potassium channel protein 4 blocker
Ion channelsPhase 2Sickle Cell Disease; Mild Cognitive Impairment; Pulmonary Fibrosis, Interstitial Lung DiseaseOct 2029
Sohag UniversityLevetiracetam
Synaptic vesicle glycoprotein 2A modulator; Voltage-gated N-type calcium channel alpha-1B subunit blocker
SV2A, Ion channelsPhase 2Generalized Convulsive Status Epilepticus–
Sahiwal medical college sahiwalLidocaine Hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 2Hemodynamics Instability–
PAEC General Hospital, IslamabadLidocaine Hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 2Postoperative Sore Throat, Cough, Hoarseness–
Ohio State University Comprehensive Cancer CenterLidocaine Hydrochloride
Sodium channel alpha subunit blocker
Ion channelsPhase 2Cutaneous Melanoma–
Federico II UniversityRanolazine
Sodium channel protein type V alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 2STEMI (ST Elevation MI)–
University of UtahRiluzole
Sodium channel alpha subunit blocker
Ion channelsPhase 2Atrial Fibrillation Paroxysmal–
S. Andrea HospitalRiluzole
Sodium channel alpha subunit blocker
Ion channelsPhase 2SCA7–
Jaeb Center for Health ResearchTonabersat
Selective T-type calcium channel inhibitor
Ion channelsPhase 2Diabetic Macular Edema–
Hangzhou Yirui Pharmaceutical TechnologyPA032
Kv1.3 potassium channel blocker
Ion channelsPhase 1Health Adult SubjectsNov 2026
Valenta Pharm JSCBenoxinate
Sodium channel alpha subunit blocker
Ion channelsPhase 1PharyngitisDec 2026
Global Neurosciences InstituteVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 1Ischemic StrokeDec 2026
University of Alabama at BirminghamNifedipine
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 1Hypertension in PregnancyDec 2026
Pacira PharmaceuticalsBupivacaine
Sodium channel protein type IV alpha subunit blocker
Ion channelsPhase 1Postoperative PainJan 2027
Indiana UniversityLacosamide
Sodium channel alpha subunit blocker
Ion channelsPhase 1Chronic PainMar 2027
Francis FarhadiGlyburide
Sulfonylurea receptor 1, Kir6.2 blocker
Ion channels, ABCC8Phase 1Acute Spinal Cord InjuryMay 2027
Beijing Friendship HospitalCrisugabalin
Calcium channel modulator (alpha-2-delta ligand)
Ion channelsPhase 1Restless Leg Syndrome (RLS)Jun 2027
Sangamo TherapeuticsST-503
Gene therapy delivering modified gene to repress Nav1.7 (SCN9A) tissue-related pain signal
Ion channelsPhase 1Chronic Neuropathic PainJul 2027
Hospital Universitario La FeOpioid-Free Anesthesia (OFA)
Multimodal non-opioid protocol: alpha-2 agonist (Dexmedetomidine), sodium channel blocker
ADRA2A, Ion channels, NMDAPhase 1Pain ManagementJul 2027
National Cancer Institute (NCI)Riluzole
Sodium channel alpha subunit blocker
Ion channelsPhase 1Advanced Malignant Solid NeoplasmSep 2027
Praxis Precision MedicinesPRAX-222
Selective sodium channel modulator targeting SCN2A mutations
Ion channelsPhase 1SCN2A-DEEFeb 2028
Institut de Recherches Internationales ServierS230815
KCNT1 activator
Ion channelsPhase 1Epileptic EncephalopathyApr 2028
Mayo ClinicDiltiazem Hydrochloride
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 1Malignant Digestive System NeoplasmApr 2028
Encoded TherapeuticsETX101
AAV9-delivered gene therapy encoding engineered transcription factor (eTFSCN1A) to increas
Ion channelsPhase 1Dravet SyndromeJun 2028
Johnny LudvigssonVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 1Type 1 DiabetesDec 2029
City of Hope Medical CenterVerapamil
Voltage-gated L-type calcium channel blocker
Ion channelsPhase 1Type 1 DiabetesApr 2030
Helios CardioAmiodarone-Infused CardiaMend patches
Topical amiodarone delivery to epicardial atrial surface
Ion channelsPhase 1Atrial Fibrillation, Postoperative–
University of California, San DiegonL-SCN2A-002
antisense oligonucleotide targeting SCN2A
Ion channelsPhase 1Genetic Disease–

Conditions

Pain, Postoperative (9) Postoperative Pain (8) Atrial Fibrillation (7) Dravet Syndrome (5) Breast Cancer (5) Pain Management (5) Type 1 Diabetes (4) Rib Fractures (4) Post Operative Pain (4) Hip Disease (4) Labor Pain (4) Acute Pain (4)

Modalities

small molecule (122), mixed (4), other (3), protein or peptide (2)

Companies

Xenon Pharmaceuticals (2) Duke University (2) University of California, San Diego (2) Assistance Publique - Hôpitaux de Paris (2) Memorial Sloan Kettering Cancer Center (2) Mayo Clinic (2) Praxis Precision Medicines (2) Ain Shams University (2) Tanta University (2) University of Illinois Chicago (2) Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) All India Institute of Medical Sciences, Jodhpur (2) University Hospital Bispebjerg and Frederiksberg (1) University of Utah (1) Nebraska Methodist Health System (1) HB BioTech (1) Johnny Ludvigsson (1) Encoded Therapeutics (1) Samsung Medical Center (1) University of Florida (1)

Related targets

SV2A (12) CACNB4 (4) CACNB2 (4) CACNB1 (4) CACNB3 (4) ABCC9 (2) ABCC8 (2) ADRA2A (2) HTR2A (2) OPRM1 (2) AGTR1 (1) NMDA (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.